Reprint

Eating Disorders and Obesity: Through the Life Course

Edited by
May 2023
276 pages
  • ISBN978-3-0365-7464-6 (Hardback)
  • ISBN978-3-0365-7465-3 (PDF)

This book is a reprint of the Special Issue Eating Disorders and Obesity: Through the Life Course that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Due to the high prevalence of Eating Disorders (ED) and obesity over the life-spam and the increasing comorbidity between both conditions, the goal of this Special Issue, “Eating Disorders and Obesity: Through the Life Course”, was to approach that situation from a broader perspective. We would like to have multidisciplinary contributions, approaching ED and Obesity as potential continuum (eg. Anorexia nervosa and obesity as extreme dimensions), looking not only to shared and differential risk factors (environmental, temperamental, biological, nutritional and neuroendocrinological between ED and obesity), but also to epidemiological studies exploring transition from one to the other, through the life-course, and its impact on the treatment outcome. We were expecting to have systematic reviews and empirical studies (cross-sectional and longitudinal manuscripts), coming from all over the globe.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
body mass index (BMI) profiles; eating disorders; obesity; treatment outcome; eating disorders; decision making; learning; treatment outcome; sensitivity to reward; sensitivity to punishment; effortful control; eating disorders; obesity; bariatric surgery; binge eating disorder; obesity; food addiction; impulsivity; emotional eating; childhood trauma questionnaire; psychotherapy; childhood obesity; attrition rate; follow-up; success rate; metabolically healthy; weight discrimination; workplace bullying; burnout; sex-specific differences; moderated mediation; overweight; obesity; underweight; adolescents; mental health; psychopathology; quality of life; eating disorder risk; network analysis; anorexia nervosa; atypical psychedelics; eating disorders; esketamine; ketamine; narrative review; severe-enduring; treatment; obesity; cardiometabolic risk factors; hypertension; dyslipidemia; tracking phenomenon; nutrigenomics; anorexia; metabolomics; metabolic phenotype; metabolism; microbiota; mass spectrometry; obesity; eating disorders; children; adolescents; anorexia nervosa; dietary inflammatory index; food frequency questionnaire; inflammation; nutrient intake; impulsivity; compulsivity; decision making; cognitive flexibility; type 2 diabetes; novelty seeking; harm avoidance; obesity; fatty kidney; glomerulopathy; CKD; ESRD; bariatric surgery; eating disorders; COVID-19 lockdown; COVID-19 Isolation Eating Scale (CIES); eating symptoms; psychological impact; obesity; children; adolescents; ghrelin; insulin resistance; leptin; adiponectin; leptin/adiponectin ratio; eating behavior; eating styles; food addiction; eating disorders; treatment outcome; cluster analysis approach; n/a; n/a